CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our 12-month target to $110 from $100, valuing shares at 11x our 2025 EPS view (initiated at $10.00; 2024 EPS raised to $9.36 from $9.13). We apply a lower multiple than MMM’s five-year forward P/E average of 16x to reflect macro headwinds, as well as litigation risks stemming from safety and environmental issues with multiple 3M products. Despite a beat on Q4 sales and earnings, MMM shares are trading sharply lower, following the company’s softer-than-anticipated 2024 EPS guidance of $9.35-$9.75 (vs. $9.82 consensus). MMM posted adj-EPS of $2.42 vs. $2.18 (+11% Y/Y), $0.11 above consensus. Q4 sales declined by roughly 1%, with organic growth remaining in negative territory (-2% Y/Y). MMM’s 2024 outlook implies muted growth across its businesses, weighed down by expected weakness in […]

By Tomi Kilgore Results for the fourth quarter beat expectations, amid strength in transportation and electronics business Shares of 3M Co. tanked Tuesday, after the consumer, industrial and healthcare-products company provided a 2024 profit outlook that was well below forecasts, which overshadowed fourth-quarter results that topped expectations. The results come as the maker of Post-it Notes, Scotch tape, N95 masks and Command strips is progressing with the spinoff of its health care business, which is expected to occur in the first half of 2024. The company (MMM) expects 2024 adjusted earnings per share of $9.35 to $9.75, compared with the current FactSet EPS consensus of $9.90. That includes a first-quarter adjusted EPS outlook of $2.00 to $2.15, which is below expectations of $2.22. The outlook reflects the health care business as part of the company for the year, but does not reflect the potential impact of funding for the public

Wells Fargo analyst Joe O’Dea maintains 3M (NYSE:MMM) with a Equal-Weight and lowers the price target from $112 to $105.

3M (NYSE:MMM) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/24/2024 9.28% Wells Fargo $112 → $105 Maintains Equal-Weight 12/19/2023 16.56% Wells Fargo $100 → $112 Maintains Equal-Weight 12/04/2023 11.36% Barclays $98 → $107 Upgrades Underweight → Equal-Weight 10/25/2023 9.28% JP Morgan $104 → $105 Maintains Neutral 10/25/2023 -13.62% RBC Capital $85 → $83 Maintains Underperform 10/25/2023 0.95% Citigroup $95 → $97 Maintains Neutral 10/25/2023 1.99% Barclays $96 → $98 Maintains Underweight 10/09/2023 -1.13% Citigroup $111 → $95 Maintains Neutral 09/15/2023 13.44% HSBC → $109 Initiates Coverage On → Hold 08/31/2023 17.61% Morgan Stanley $102 → $113 Upgrades Underweight → Equal-Weight 08/29/2023 24.89% Mizuho → $120 Reiterates Neutral → Neutral 08/29/2023 — Wolfe Research Upgrades Underperform → Peer Perform 07/26/2023 6.16% Morgan Stanley $100 → $102 Maintains Underweight 07/26/2023 15.52% Citigroup $100 → $111 Maintains Neutral 07/26/2023 4.08% RBC Capital $95 →